Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

European Commission grants orphan drug designation to sirolimus for sickle cell disease

Jan. 25, 2018

Imara initiates proof-of-concept phase II study of IMR-687 in sickle cell anemia

Jan. 23, 2018

New phase III trial explores use of BAX-111 in pediatric severe hereditary von Willebrand disease

Jan. 22, 2018

Spark's SPK-8011 given FDA orphan drug status for hemophilia A

Jan. 18, 2018

Darbepoetin alfa biosimilar JR-131 demonstrates equivalence in phase III study

Jan. 18, 2018

Endari now available in U.S. for sickle cell disease in adult and pediatric patients

Jan. 18, 2018

FDA accepts Ruconest sBLA for review

Jan. 17, 2018

Bioverativ conducts phase III trials with BIVV-009 in primary cold agglutinin disease

Jan. 17, 2018

European Commission approves Adynovi for hemophilia A

Jan. 15, 2018

FronThera US Pharmaceuticals presents novel hemoglobin modifier compounds

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...